Increased mortality in young candidemia patients associated with presence of a Candida albicans general-purpose genotype

Journal of Clinical Microbiology

Volumn 49, Issue 9, 2011, Pages 3250-3256

  Schmid, J ^a   Tortorano, A M ^b   Jones, G ^a   Lazzarini, C ^b   Zhang, N ^a   Bendall, M J ^a   Cogliati, M ^b   Wattimena, S ^a   Klingspor, L ^c   Bouges Michel, Claire ^d   Poilane, Isabelle ^e   Bougnoux, Marie Elisabeth ^f,t   Dunand, Jean ^f   Galeazzi, Guy ^g   Bretagne, Stéphane ^h   Fauchet, Nathalie ⁱ   Forget, Elisabeth ^j   Botterel, Françoise ^k   Bonnal, Christine ^k   Eloy, Odile ^l   Lawrence, Christine ^m   David, Marie Françoise ⁿ   Mihaila, Liliana ⁿ   Chachaty, Elisabeth ^o   Adam, Olivier ^o   Chochillon, Christian ^p   Paugam, André ^q   Baixench, Marie Thérèse ^q   Cornet, Muriel ^r   Escande, Marie Christine ^s   Challier, Svetlana ^t   Dannaoui, Eric ^u   Datry, Annick ^v   Laklache, Houria ^v   Lminmouni, Bader ^v   Brun, Sophie ^v   Poirot, Jean Louis ^w   Lacroix, Claire ^x   Moissenet, Didier ^y   Develoux, Michel ^z   Bonacorsi, Stéphane ^aa   Tortorano, Anna Maria ^ab   Dho, Giovanna ^ab   Prigitano, Anna ^ab   Grancini, Anna ^ab   Ossi, Cristina ^ab   Giuliani, Giuseppe ^ab   Tejada, Milvana ^ab   Vismara, Chiara ^ab   Viola, Giovanna ^ab   Cavanna, Caterina ^ab   Passera, Marco ^ab   Farina, Claudio ^ab   Grossi, Antonio ^ab   Pinsi, Gabriele ^ab   Ceraminiello, Antonio ^ab   Casella, Pietro ^ab   Agrappi, Carlo ^ab   Sturla, Carla ^ab   Lombardi, Gianluigi ^ab   LoCascio, Giuliana ^ab   Deiana, Maria Luisa ^ab   Garau, Maria Graziella ^ab   Klingspor, Lean ^ab   Weigel, Andrea ^ab   Graf, Barbara ^ab   Ruhnke, Markus ^ab   Peman, Javier ^ab   Salonen, Juha H ^ab   Meurman, Olli ^ab   Sarkkinen, Hannu ^ab   Sabino, Raquel ^ab   Videira, Zélia ^ab   Kirschner, Harald ^ab   Lass Flörl, Cornelia ^ab   Maass, Matthias ^ab   Watschinger, Regina ^ab   Willinger, Birgit ^ab   Zeitlberger, Eva Maria ^ab   Velegraki, Aristea ^ab   Antonopoulou, Stavroula ^ab   Dimopoulos, George ^ab   Kouskouni, Evangelia ^ab   Petinaki, Efthimia ^ab   Trikka Graphakos, Eleftheria ^ab   Vyzantiadis, A Timoleon ^ab   Zerva, Loukia ^ab   more..

^a MASSEY UNIVERSITY   (New Zealand)

^b UNIVERSITY OF MILAN   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d AVICENNE HOSPITAL   (France)

^e HÔPITAL JEAN VERDIER   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

^g HÔPITAL LOUIS MOURIER   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^j BEAUJON HOSPITAL   (France)

^k BICÊTRE HOSPITAL   (France)

^l CENTRE HOSPITALIER DE VERSAILLES   (France)

^m RAYMOND POINCARÉ HOSPITAL   (France)

ⁿ HÔPITAL PAUL BROUSSE   (France)

^o INSTITUT GUSTAVE ROUSSY   (France)

^p BICHAT HOSPITAL   (France)

^q Hôpital Cochin ^*  (France)

^r HÔTEL DIEU   (France)

^s INSTITUT CURIE   (France)

^t HÔPITAL NECKER ENFANTS MALADES   (France)

^u HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^v PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^w HÔPITAL SAINT ANTOINE   (France)

^x SAINT LOUIS HOSPITAL   (France)

^y SERVICE DE DERMATOLOGIE   (France)

^z HÔPITAL TENON   (France)

^aa HÔPITAL ROBERT DEBRÉ   (France)

^ab NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL VIRULENCE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDEMIA; CHILD; CLADISTICS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CANDIDA ALBICANS; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

CANDIDA ALBICANS;

EID: 80052218564     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00941-11     Document Type: Article

References (44)

1. Ahmed, R., M. B. Oldstone, and P. Palese. 2007. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat. Immunol. 8:1188-1193.
2. Ashman, R. B., et al. 2004. Innate versus adaptive immunity in Candida albicans infection. Immunol. Cell Biol. 82:196-204.
3. Ausubel, F. M., et al. 2006. Current protocols in molecular biology. John Wiley and Sons, Inc., New York, NY.
4. Bliss, J. M., K. P. Basavegowda, W. J. Watson, A. U. Sheikh, and R. M. Ryan. 2008. Vertical and horizontal transmission of Candida albicans in very low birth weight infants using DNA fingerprinting techniques. Pediatr. Infect. Dis. J. 27:231-235.
5. Dannaoui, E., et al. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. Clin. Microbiol. Infect. 16:863-869.
6. Giblin, L., et al. 2001. A DNA polymorphism specific to Candida albicans strains exceptionally successful as human pathogens. Gene 272:157-164.
7. Gudlaugsson, O., et al. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37:1172-1177.
8. Holland, B. R., and J. Schmid. 2005. Selecting representative model microorganisms. BMC Microbiol. 5:26.
9. Horiuchi, S. 2000. Greater lifetime expectations. Nature 405:744-745.
10. Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmerman. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829.
11. Lass-Flörl, C. 2009. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52:197-205.
12. Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963.
13. Lin, X., and D. Zhang. 1999. Inference in generalized additive mixed models by using smoothing splines. J. R. Stat. Soc. Series B Stat. Methodol. 55:381-400.
14. Lott, T. J., B. P. Holloway, D. A. Logan, R. Fundyga, and J. Arnold. 1999. Towards understanding the evolution of the human commensal yeast Candida albicans. Microbiology 145:1137-1143.
15. MacCallum, D. M., et al. 2009. Property differences among the four major Candida albicans strain clades. Eukaryot. Cell 8:373-387.
16. Magee, P. T. 2010. Fungal pathogenicity and morphological switches. Nat. Genet. 42:560-561.
17. Marco, F., et al. 1999. Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3. J. Clin. Microbiol. 37:2817-2828.
18. Matzel, L. D., H. Grossman, K. Light, D. Townsend, and S. Kolata. 2008. Age-related declines in general cognitive abilities of Balb/C mice are associated with disparities in working memory, body weight, and general activity. Learn. Mem. 15:733-746.
19. Morgan, J. 2005. Global trends in candidemia: review of reports from 1995-2005. Curr. Infect. Dis. Rep. 7:429-439.
20. Noble, S. M., S. French, L. A. Kohn, V. Chen, and A. D. Johnson. 2010. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42:590-598.
21. Odds, F. C. 2009. In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1. FEMS Yeast Res. 9:1091-1101.
22. Odds, F. C., et al. 2007. Molecular phylogenetics of Candida albicans. Eukaryot. Cell 6:1041-1052.
23. Oh, S.-H., et al. 2005. Functional specificity of Candida albicans Als3p proteins and clade specificity of ALS3 alleles discriminated by the number of copies of the tandem repeat sequence in the central domain. Microbiology 151:673-681.
24. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
25. R Development Core Team. 2009. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
26. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
27. Schmid, J., et al. 2008. Differences in mortality between patients infected with different Candida albicans genotypes, abstr. S2:1, p. 19. Abstr. 9th ASM Conf. Candida Candidiasis, Jersey City, NJ.
28. Schmid, J., et al. 1999. Evidence for a general-purpose genotype in Candida albicans, highly prevalent in multiple geographic regions, patient types and types of infection. Microbiology 145:2405-2414.
29. Schmid, J., P. R. Hunter, G. C. White, A. K. Nand, and R. D. Cannon. 1995. Physiological traits associated with success of Candida albicans strains as commensal colonisers and pathogens. J. Clin. Microbiol. 33:2920-2926.
30. Schmid, J., M. Rotman, B. Reed, C. L. Pierson, and D. R. Soll. 1993. Genetic similarity of Candida albicans strains from vaginitis patients and their partners. J. Clin. Microbiol. 31:39-46.
31. Schmid, J., et al. 1995. Evidence for nosocomial transmission of Candida albicans obtained by Ca3 fingerprinting. J. Clin. Microbiol. 33:1223-1230.
32. Solana, R., G. Pawelec, and R. Tarazona. 2006. Aging and innate immunity. Immunity 24:491-494.
33. Soll, D. R., et al. 1991. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J. Clin. Microbiol. 29:1702-1710.
34. Szabo, E. K., and D. M. MacCallum. 2011. The contribution of mouse models to our understanding of systemic candidiasis. FEMS Microbiol. Lett. 320:1-8.
35. Timmers, G. J., et al. 2000. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial. Bone Marrow Transplant. 25: 879-884.
36. Tortorano, A. M., et al. 2004. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur. J. Clin. Microbiol. Infect. Dis. 23:317-322.
37. Turnbull, B. W. 1976. The empirical distribution function with arbitrarily grouped censored and truncated data. J. R. Stat. Soc. Series B Stat. Methodol. 38:290-295.
38. Vanhee, L. M. E., H. J. Nelis, and T. Coenye. What can be learned from genotyping of fungi? Med. Mycol. 48:S60-S69.
39. Weng, N.-P. 2006. Aging of the immune system: how much can the adaptive immune system adapt? Immunity 24:495-499.
40. Zaoutis, T. 2010. Candidemia in children. Curr. Med. Res. Opin. 26:1761-1768.
41. Zhang, N., R. D. Cannon, B. Holland, M. Patchett, and J. Schmid. 2010. Impact of genetic background on allele selection in a highly mutable Candida albicans gene, PNG2. PLoS One 5:e9614.
42. Zhang, N., et al. 2003. Sixty alleles of the ALS7 open reading frame in Candida albicans: ALS7 is a hypermutable contingency locus. Genome Res. 13:2005-2017.
43. Zhang, N., et al. 2009. Distribution of mutations distinguishing the most prevalent disease-causing Candida albicans genotype from other genotypes. Infect. Genet. Evol. 9:493-500.
44. Zhao, X., et al. 2007. Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates. Fungal Genet. Biol. 44:1298-1309.